InvestorsHub Logo
Followers 23
Posts 1907
Boards Moderated 0
Alias Born 12/14/2009

Re: None

Monday, 04/05/2010 8:02:17 PM

Monday, April 05, 2010 8:02:17 PM

Post# of 59551
Here is what I received from IMGG via email for all those wondering. This is a cut and paste!





Imaging3 is pleased to announce that Dean Janes has submitted the company’s latest response to the FDA today, Monday, April 5, 2010.



If you have any questions, please contact Investor Relations by e-mail or by calling (800) 900-9729.



Sincerely,



Investor Relations
Imaging3, Inc.
Burbank CA 91505
(800) 900-9729
info@imaging3.com
www.imaging3.com





Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company.



We apologize for any inconvenience. If you would like to be removed from this mailing list, please reply to this email with the subject line “Unsubscribe”. Thank you.